Author

Anthony B. Nesburn

University of California, Irvine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Afshana QuadiriiD· 2 shared Aziz Alami ChentoufiiD· 2 shared Baruch D. Kuppermann· 2 shared Hawa VahediD· 2 shared Lbachir BenMohamediD· 2 shared Swayam PrakashiD· 2 shared Daniel Gil· 1 shared David S. Boyer· 1 shared

Activity by Year

2018-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Afshana QuadiriORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Pan-Beta-Coronavirus Vaccine Bearing Conserved and Asymptomatic B- and T-Cell Epitopes Protect Against Highly Pathogenic Delta and Highly Transmissible Omicron SARS-CoV-2 Variants of Concern.

Hawa Vahed, Swayam Prakash, Afshana Quadiri, Izabela Coimbra Ibraim, Etinosa Omorogieva, Swena Patel, Jimmy Tadros, Emma Jane Liao, Lauren Lau, Aziz Alami Chentoufi, Anthony B. Nesburn, Baruch D. Kuppermann, Jeffrey B. Ulmer, Daniel Gil, Lbachir BenMohamed

This paper develops a multi-epitope vaccine targeting conserved B- and T-cell epitopes from SARS-CoV-2, showing protection against Delta and Omicron variants in a mouse model.

Human Vaccines & Immunotherapeutics · Jul 4, 2025Peer-reviewedImmunology

Tissue-Targeted Prime/Pull/Keep Therapeutic Herpes Simplex Virus Vaccine Protect Against Recurrent Ocular Herpes Diseases in HLA-A*0201 Transgenic Rabbits

Aziz Alami Chentoufi, Swayam Prakash, Hawa Vahed, Sweta Karan, Afshana Quadiri, Anthony B. Nesburn, Lbachir BenMohamed

This study tests a prime/pull/keep HSV-1 vaccine in HLA-A*0201 transgenic rabbits, showing it reduces corneal herpes infection by mobilizing and retaining CD8+ T cells in infected tissues.

Journal of Virology · Apr 10, 2025Peer-reviewedImmunology

Role of STING complex in differential retrograde signaling in cybrids with K versus H haplogroup mtDNA

Kevin Schneider, Marilyn Chwa, Shari R. Atilano, Sonali Nashine, Nitin Udar, David S. Boyer, S. Michal Jazwinski, Michael V. Miceli, Anthony B. Nesburn, Baruch D. Kuppermann, M. Cristina Kenney

The paper investigates differential retrograde signaling via the STING pathway in cybrids with H and K mtDNA haplogroups, finding distinct gene expression changes linked to disease pathways.

bioRxiv · Aug 28, 2018 · PreprintCell Biology